Document Detail


Multiparameter flow cytometry for the diagnosis and monitoring of small GPI-deficient cellular populations.
MedLine Citation:
PMID:  20533383     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Glycosyl-phosphatidylinositol (GPI)-negative blood cells are diagnostic for Paroxysmal Nocturnal Hemoglobinuria (PNH). Marrow failure states are often associated with GPI-negative cell populations. Quantification of small clonal populations of GPI-negative cells influences clinical decisions to administer immunosuppressive therapy in marrow failure states (aplastic anemia or myelodysplastic syndrome) and to monitor minimal residual disease after allogeneic blood or marrow transplantation (BMT). We studied the reliability of high-resolution flow cytometry markers operating at the limits of detection.
METHODS: We performed serial quantification of the PNH clone size in 38 samples using multiparameter flow cytometry. Granulocytes, monocytes, and RBCs were gated using forward and side scatter as well as lineage-specific markers. The GPI-linked markers fluorescent aerolysin (FLAER), CD55, and CD59 were comparatively evaluated. We also evaluated CD16 on granulocytes and CD14 on monocytes. The sensitivity of detection by each marker was further defined by serial dilution experiments on a flow-sorted sample. Two patients had quantification of their GPI-negative clones before and after allogeneic BMT.
RESULTS: FLAER was the most discriminant marker and allowed identification of 0.1% of GPI-negative cells despite other markers having superior signal-to-noise characteristics. CD14 and CD16 were inferior to CD55 at lower concentrations and in clinical application.
CONCLUSIONS: Multiparameter flow cytometry permits quantification of small GPI-negative clones with a sensitivity limit of about 0.1%. The single most reliable marker to monitor small granulocyte or monocyte PNH clones is FLAER, especially in conditions such as myelodysplastic syndromes or BMT, when traditional GPI-linked surface marker expression can be significantly altered. © 2010 International Clinical Cytometry Society.
Authors:
Minoo Battiwalla; Mehmet Hepgur; Dalin Pan; Philip L McCarthy; Manmeet S Ahluwalia; Susan H Camacho; Petr Starostik; Paul K Wallace
Related Documents :
10851413 - Acetabular blood flow during total hip arthroplasty.
1624563 - Detection of borreliacidal antibodies in hamsters by using flow cytometry.
367603 - Computer analysis of oximetry data in cardiac catheterization.
Publication Detail:
Type:  Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural     Date:  2010-06-07
Journal Detail:
Title:  Cytometry. Part B, Clinical cytometry     Volume:  78     ISSN:  1552-4957     ISO Abbreviation:  Cytometry B Clin Cytom     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-11-05     Completed Date:  2011-02-28     Revised Date:  2011-09-13    
Medline Journal Info:
Nlm Unique ID:  101235690     Medline TA:  Cytometry B Clin Cytom     Country:  United States    
Other Details:
Languages:  eng     Pagination:  348-56     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 International Clinical Cytometry Society.
Affiliation:
Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA. kunashni@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Antigens, CD14 / analysis,  immunology
Antigens, CD55 / analysis,  immunology
Antigens, CD59 / analysis,  immunology
Bacterial Toxins / analysis
Biological Markers / analysis
Blood Cells / chemistry*,  immunology
Bone Marrow Transplantation / immunology
Female
Flow Cytometry / methods*
Fluorescent Dyes / analysis
GPI-Linked Proteins / analysis,  immunology
Glycosylphosphatidylinositols / analysis*,  deficiency*,  immunology
Granulocytes / immunology
Hemoglobinuria, Paroxysmal / diagnosis*,  immunology
Humans
Male
Middle Aged
Monitoring, Physiologic / methods*
Monocytes / immunology
Pore Forming Cytotoxic Proteins / analysis
Receptors, IgG / analysis,  immunology
Reproducibility of Results
Young Adult
Grant Support
ID/Acronym/Agency:
5 P30 CA016056-29/CA/NCI NIH HHS; P30 CA016056-329022/CA/NCI NIH HHS; P30 CA016056-339022/CA/NCI NIH HHS; P30 CA016056-33S59022/CA/NCI NIH HHS; P30 CA016056-33S69022/CA/NCI NIH HHS; S10 RR022335-01A1/RR/NCRR NIH HHS; S10 RR022335-01A10001/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Antigens, CD14; 0/Antigens, CD55; 0/Antigens, CD59; 0/Bacterial Toxins; 0/Biological Markers; 0/FCGR3B protein, human; 0/Fluorescent Dyes; 0/GPI-Linked Proteins; 0/Glycosylphosphatidylinositols; 0/Pore Forming Cytotoxic Proteins; 0/Receptors, IgG; 101754-01-2/CD59 protein, human; 53126-24-2/aerolysin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disor...
Next Document:  Levels of circulating endothelial cells in normotensive and severe preeclamptic pregnancies.